Rahul Banerjee, MD

Rahul Banerjee, MD, FACP, of Fred Hutchinson Cancer Center, discusses strategies to improve the benefits of CAR T-cell therapy in multiple myeloma.

Rahul Banerjee, MD, FACP, discusses the use of nivolumab in multiple myeloma or non-Hodgkin lymphoma after progression following CAR T-cell therapy.

Rahul Banerjee, MD, discusses how to navigate the obstacles in interpreting Kaplan-Meier curves.

Rahul Banerjee, MD, discusses the rationale to create a supportive mobile health companion app for CAR T-cell therapy recipients and their caregivers ​to use throughout the therapeutic process.

Breaking down your oral presentation into specific content-related and delivery-related domains can help you remember what to rehearse and what to include.